Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Q&A: Revised TIR From AAMI Targets IFUs For Device Processing

Executive Summary

The Association for the Advancement of Medical Instrumentation’s updated TIR12:2020 aims to standardize instructions for use for processing and increase awareness of how end users interpret IFUs. A co-chair of the AAMI working group that oversees TIR12 explained more in an interview with Medtech Insight.

You may also be interested in...



FDA Warning Letter Recap, November 2021: 3 Device Makers Cited After On-Site Inspections

Invacare, Smiths Medical and CellEra were cited for quality systems and Medical Device Reporting violations in the only device-related warning letters released by the agency last month.

FDA Preps Device Makers To Use eSTAR For De Novo Requests

Manufacturers can’t use the US FDA’s voluntary eSTAR product submission program for de novo requests until January – but they can start practicing now on how to use eSTAR for that review pathway.

FDA Warning Letter Prompts Company To Stop Selling Baby-Monitoring Device

For five years Owlet Baby Care Inc. has said its Smart Sock monitoring product isn’t a medical device. But the US FDA disagreed – and finally put its foot down in a warning letter that told the company to come into compliance or stop selling the sock. So Owlet decided to do both.

Topics

UsernamePublicRestriction

Register

MT143629

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel